Theravance Biopharma (TBPH) Work In Process (2013 - 2018)
Theravance Biopharma (TBPH) posted quarterly Work In Process of $3.6 million for Q3 2018, up 379.89% year-over-year from $756000.0 in Q3 2017, and up 8.33% quarter-over-quarter from $3.3 million in Q2 2018.
Theravance Biopharma (TBPH) Work In Process (2013 - 2018) Analysis & Trends
Theravance Biopharma (TBPH) has reported Work In Process for 5 consecutive years, with $3.6 million the latest figure, recorded in Q3 2018.
- In Q3 2018, Work In Process rose 379.89% year-over-year to $3.6 million; the TTM figure through Sep 2018 stood at $3.6 million (up 379.89% YoY), while the FY2017 annual figure was $66000.0, down 97.49% from the prior year.
- Work In Process rose to $3.6 million in Q3 2018 per TBPH's latest filing, from $3.3 million in the prior quarter.
- Across five years, Work In Process topped out at $3.6 million in Q3 2018 and bottomed at $66000.0 in Q4 2017.
- Historically, Work In Process has averaged $1.9 million across 4 years, with a median of $2.0 million in 2018.
- Annual changes were most pronounced in 2017 — Work In Process plunged 97.49% — and 2018, when it surged 379.89%.
- Theravance Biopharma's Work In Process stood at $145000.0 in 2014, then surged by 1711.72% to $2.6 million in 2016, then slumped by 97.49% to $66000.0 in 2017, then surged by 5396.97% to $3.6 million in 2018.
- Business Quant data shows TBPH's Work In Process at $3.6 million in Q3 2018, $3.3 million in Q2 2018, and $2.0 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 3.63 Mn |
| Jun 30, 2018 | 3.35 Mn |
| Mar 31, 2018 | 1.99 Mn |
| Dec 31, 2017 | 66,000.00 |
| Sep 30, 2017 | 756,000.00 |
| Jun 30, 2017 | 3.38 Mn |
| Mar 31, 2017 | 2.63 Mn |
| Dec 31, 2016 | 2.63 Mn |
| Sep 30, 2016 | 837,000.00 |
| Jun 30, 2016 | 1.84 Mn |
| Mar 31, 2016 | 1.76 Mn |
| Dec 31, 2014 | 145,000.00 |
| Sep 30, 2014 | 812,000.00 |
| Jun 30, 2014 | 2.28 Mn |
| Mar 31, 2014 | 2.23 Mn |
| Dec 31, 2013 | 360,000.00 |